Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,200
Closed -$693K 1207
2020
Q4
$693K Hold
17,200
﹤0.01% 1024
2020
Q3
$455K Buy
+17,200
New +$449K ﹤0.01% 1051
2015
Q3
Sell
-11,045
Closed -$433K 1448
2015
Q2
$433K Buy
11,045
+1,208
+12% +$47.2K ﹤0.01% 1111
2015
Q1
$367K Hold
9,837
﹤0.01% 1165
2014
Q4
$373K Hold
9,837
﹤0.01% 1157
2014
Q3
$350K Hold
9,837
﹤0.01% 1142
2014
Q2
$415K Hold
9,837
﹤0.01% 1117
2014
Q1
$361K Hold
9,837
﹤0.01% 1131
2013
Q4
$348K Hold
9,837
﹤0.01% 1139
2013
Q3
$302K Hold
9,837
﹤0.01% 1088
2013
Q2
$244K Buy
+9,837
New +$239K ﹤0.01% 1085

Other funds holding AVNT

Axa's AVNT Position: Q1 2021 in Review

Axa sold out of Avient (AVNT) in Q1 2021, closing a stake of 17,200 shares — an estimated $693K sold.

Axa first reported a position in AVNT in Q2 2013 and held it in 11 quarters. The position peaked at $693K in Q4 2020. 265 funds tracked by Wall St. Rank hold AVNT as of Q1 2021.

  • Axa reported no remaining Avient position as of Q1 2021 after selling out during the quarter.
  • Axa sold 17,200 Avient shares in Q1 2021, an estimated $693K.
  • Axa first reported a position in Avient in Q2 2013 and held it in 11 quarters.
  • Axa's Avient position peaked at $693K in Q4 2020.
  • 265 funds tracked by Wall St. Rank held Avient as of Q1 2021.

Based on Axa's 13F filing for Q1 2021, filed 14 May 2021.